Strikethrough Ventures is dedicated to advancing healthcare innovation by serving as an early-stage funding partner for promising companies developed through the high success rate Biodesign system best practices. We provide catalytic, mission-driven capital, structured to bridge the critical funding gap between idea and commercialization (where traditional investors are often absent). Unlike conventional venture capital, any financial returns generated are reinvested directly into the fund, creating a sustainable, evergreen model that continually supports new innovations. By combining philanthropic resources with the expertise of healthcare professionals, industry leaders, and donors, Strikethrough Ventures fosters a dynamic ecosystem that accelerates the pace of early-stage development for high impact healthcare innovation.